RULE NO.:RULE TITLE:
64B15-14.014Standards of Practice for the Treatment of Gender Dysphoria in Minors
NOTICE OF CHANGE
Notice is hereby given that the following changes have been made to the proposed rule in accordance with subparagraph 120.54(3)(d)1., F.S., published in Vol. 48 No. 221, November 14, 2022 issue of the Florida Administrative Register.
The changes are in response to written comments submitted by the public and discussion and subsequent vote by the board at a public rule hearing held February 10, 2023. The changes are as follows:
64B15-14.014 Standards of Practice for the Treatment of Gender Dysphoria in Minors.
(1) No change.
(2) Nonsurgical treatments for the treatment of gender dysphoria in minors may continue to be performed under the auspices of Institutional Review Board (IRB) approved, investigator-initiated clinical trials conducted at any of the Florida medical schools set forth in Section 458.3145(1)(i), Florida Statutes. Such clinical trials must include long term longitudinal assessments of the patients’ physiologic and psychologic outcomes.
(3) renumbered (2) No change.
Rulemaking Authority 458.331(1)(v), F.S. Law Implemented 458.331(1)(v), F.S. History-New
THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Danielle Terrell, Executive Director, Board of Osteopathic Medicine/MQA, 4052 Bald Cypress Way, Bin # C06, Tallahassee, Florida 32399-3256, or by email at Danielle.Terrell@flhealth.gov.
